Folinic Acid Market by Form (Tablets, Soft Gels, Lozenges, and Others), By Source (Vegetables, Fruits, and Others), By Application (Food & Beverages, Pharmaceuticals, Nutraceuticals, and Others), By Region – Global Opportunities and Forecast, 2020-2027
1. Executive Summary
1.1. Key Market Insights
2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Regional Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology
2.5.1. Research Data
2.5.2. Primary Data
2.5.3. Demand Side and Supply Side Analysis
2.5.4. Market Size Estimation
2.5.5. Research Assumptions
3. Global Folinic Acid Market - Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Value Chain Analysis
3.4. Market Drivers
3.5. Market Restraints
3.6. Market Trends
4. Global Folinic Acid Market Revenue Forecast till 2027
5. Global Folinic Acid Market by Form Revenue Forecast till 2027
5.1. Tablets
5.2. Soft Gels
5.3. Lozenges
5.4. Others
6. Global Folinic Acid Market by Source Revenue Forecast till 2027
6.1. Vegetables
6.2. Fruits
6.3. Others
7. Global Folinic Acid Market by Application Revenue Forecast till 2027
7.1. Food & Beverages
7.2. Pharmaceutical
7.3. Nutraceuticals
7.4. Others
8. Global Folinic Acid Market by Region Revenue Forecast till 2027
8.1. North America Folinic Acid Market Revenue Forecast till 2027
(Option 1: As a part of the free 25% customization)
8.1.1. North America Folinic Acid Market by Form
8.1.1.1. Tablets
8.1.1.2. Soft Gels
8.1.1.3. Lozenges
8.1.1.4. Others
8.1.2. North America Folinic Acid Market by Source
8.1.2.1. Vegetables
8.1.2.2. Fruits
8.1.2.3. Others
8.1.3. North America Folinic Acid Market by Application
8.1.3.1. Food & Beverages
8.1.3.2. Pharmaceutical
8.1.3.3. Nutraceuticals
8.1.3.4. Others
8.1.4. United States of America (US) Folinic Acid Market All-Up
8.1.5. Canada Folinic Acid Market All-Up
8.2. Europe Folinic Acid Market Revenue Forecast till 2027
(Option 2: As a part of the free 25% customization)
8.2.1. Europe Folinic Acid Market by Form
8.2.1.1. Tablets
8.2.1.2. Soft Gels
8.2.1.3. Lozenges
8.2.1.4. Others
8.2.2. Europe Folinic Acid Market by Source
8.2.2.1. Vegetables
8.2.2.2. Fruits
8.2.2.3. Others
8.2.3. Europe Folinic Acid Market by Application
8.2.3.1. Food & Beverages
8.2.3.2. Pharmaceutical
8.2.3.3. Nutraceuticals
8.2.3.4. Others
8.2.4. United Kingdom (UK) Folinic Acid Market All-Up
8.2.5. Germany Folinic Acid Market All-Up
8.2.6. France Folinic Acid Market All-Up
8.2.7. Spain Folinic Acid Market All-Up
8.2.8. Rest of Europe Folinic Acid Market All-Up
8.3. Asia-Pacific Folinic Acid Market Revenue Forecast till 2027
(Option 3: As a part of the free 25% customization)
8.3.1. Asia-Pacific Folinic Acid Market by Form
8.3.1.1. Tablets
8.3.1.2. Soft Gels
8.3.1.3. Lozenges
8.3.1.4. Others
8.3.2. Asia-Pacific Folinic Acid Market by Source
8.3.2.1. Vegetables
8.3.2.2. Fruits
8.3.2.3. Others
8.3.3. Asia-Pacific Folinic Acid Market by Application
8.3.3.1. Food & Beverages
8.3.3.2. Pharmaceutical
8.3.3.3. Nutraceuticals
8.3.3.4. Others
8.3.4. China Folinic Acid Market All-Up
8.3.5. India Folinic Acid Market All-Up
8.3.6. Japan Folinic Acid Market All-Up
8.3.7. Rest of APAC Folinic Acid Market All-Up
8.4. Rest of the World Folinic Acid Market Revenue Forecast till 2027
(Option 4: As a part of the free 25% customization)
8.4.1. Rest of the World Folinic Acid Market by Form
8.4.1.1. Tablets
8.4.1.2. Soft Gels
8.4.1.3. Lozenges
8.4.1.4. Others
8.4.2. Rest of the World Folinic Acid Market by Source
8.4.2.1. Vegetables
8.4.2.2. Fruits
8.4.2.3. Others
8.4.3. Rest of the World Folinic Acid Market by Application
8.4.3.1. Food & Beverages
8.4.3.2. Pharmaceutical
8.4.3.3. Nutraceuticals
8.4.3.4. Others
8.4.4. Brazil Folinic Acid Market All-Up
8.4.5. South Africa Folinic Acid Market All-Up
8.4.6. Saudi Arabia Folinic Acid Market All-Up
8.4.7. UAE Folinic Acid Market All-Up
8.4.8. Rest of world (remaining countries of the LAMEA region) Folinic Acid Market All-Up
9. Competitive Landscape Analysis
9.1. Porter’s Five Forces Analysis
9.2. Industry – Competitive Landscape
9.3. Market Presence (Intensity Mapping)
9.4. Key Strategic Market Developments
10. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
10.1. DSM N.V
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Footprint & Employee Strength
10.1.4. Product Offerings
10.1.5. Financials
10.1.6. Key Company Developments
10.2. BASF SE
10.2.1. Company Overview
10.2.2. Key Executives
10.2.3. Footprint & Employee Strength
10.2.4. Product Offerings
10.2.5. Financials
10.2.6. Key Company Developments
10.3. Parchem Fine & Specialty Chemicals
10.3.1. Company Overview
10.3.2. Key Executives
10.3.3. Footprint & Employee Strength
10.3.4. Product Offerings
10.3.5. Financials
10.3.6. Key Company Developments
10.4. Jiangxi Tianxin Pharmaceutical Co. Ltd
10.4.1. Company Overview
10.4.2. Key Executives
10.4.3. Footprint & Employee Strength
10.4.4. Product Offerings
10.4.5. Financials
10.4.6. Key Company Developments
10.5. Medicamen Biotech Ltd
10.5.1. Company Overview
10.5.2. Key Executives
10.5.3. Footprint & Employee Strength
10.5.4. Product Offerings
10.5.5. Financials
10.5.6. Key Company Developments
10.6. Xinjiang Wujiaqu Xingnong Cycle Chemical Co. Ltd
10.6.1. Company Overview
10.6.2. Key Executives
10.6.3. Footprint & Employee Strength
10.6.4. Product Offerings
10.6.5. Financials
10.6.6. Key Company Developments
10.7. Zydus Pharmaceuticals Ltd
10.7.1. Company Overview
10.7.2. Key Executives
10.7.3. Footprint & Employee Strength
10.7.4. Product Offerings
10.7.5. Financials
10.7.6. Key Company Developments
10.8. Emcure Pharmaceuticals Ltd
10.8.1. Company Overview
10.8.2. Key Executives
10.8.3. Footprint & Employee Strength
10.8.4. Product Offerings
10.8.5. Financials
10.8.6. Key Company Developments
11. About GMI Research
*Details on Financials might not be available in case of unlisted/private companies.
- Published Date: Jun-2020
- Report Format: Excel/PPT
- Report Code: UP494A-00-0620
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Folinic Acid Market by Form (Tablets, Soft Gels, Lozenges, and Others), By Source (Vegetables, Fruits, and Others), By Application (Food & Beverages, Pharmaceuticals, Nutraceuticals, and Others), By Region – Global Opportunities and Forecast, 2020-2027
$ 4,499.00 – $ 6,649.00
Why GMI Research
